Igenomix
42
3
4
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.5%
4 terminated/withdrawn out of 42 trials
82.6%
-3.9% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (42)
New Strategies to Evaluate the Reproductive Tract Microbiome
Role: lead
Pilot Study of Discarded Blastocysts
Role: lead
Correlation of the Genetic Constitution of the Spent Blastocyst Media
Role: lead
RCT Study to Validate niPGT-A Clinical Benefit.
Role: lead
International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures
Role: lead
International Pilot Study for Dual Non-invasive Assesment of Embryo Development
Role: lead
Outcome of Embryos Transferred After Initial Chaotic Results on PGT-A
Role: collaborator
Non-Euploid Embryo Transfer (NEET) Registry
Role: collaborator
Study of Abnormally Fertilized Embryos
Role: lead
Ovarian PRP for Diminished Ovarian Reserve
Role: collaborator
Microbiome and Endometrial Receptivity in Obese Infertile Women
Role: collaborator
Multi-center Study to Validate niPGT-A
Role: lead
Clinical Study of PGT-A Versus PGT-A+ERA
Role: lead
Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy
Role: lead
Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
Role: lead
Human Sperm Markers of Cryodamage Resistance
Role: collaborator
Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients
Role: lead
Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor
Role: lead
RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2
Role: collaborator
Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis
Role: collaborator